Literature DB >> 16472799

Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.

Larry Baum1, Ho Keung Ng, Kam Sang Woo, Brian Tomlinson, Timothy Hudson Rainer, Xiangyan Chen, Wing Sze Cheung, Daniel Kam Yin Chan, G Neil Thomas, Cindy See Wai Tong, Ka Sing Wong.   

Abstract

OBJECTIVES: Paraoxonase (PON1), an enzyme associated with high-density lipoprotein (HDL) particles, inhibits oxidation and atherogenesis. We sought to investigate the association of the PON1 Q192R polymorphism with stroke and heart disease. DESIGN AND METHODS: In a case control study, we genotyped 242 ischemic stroke, 231 myocardial infarction (MI), and 310 healthy control subjects, all Chinese.
RESULTS: R-containing genotypes (R+) were associated with vascular disease, OR = 1.5, P = 0.03. RR was increased in MI patients who were either smokers (OR = 3.1, P = 0.01), male, or younger than 60. R+ but not RR genotypes were increased in stroke patients, particularly large artery type (OR = 2.6 and P = 0.02 for R+, OR = 1.0 for RR) or among smokers. The relative dearth of RR in stroke might be due to earlier MI or death in at-risk people, such as smokers. R+ genotypes were increased with stroke in hypertensive (OR = 2.1, P = 0.02) but not normotensive (OR = 1.0) subjects.
CONCLUSIONS: PON1 192R+ genotypes were associated with stroke and MI, particularly in subsets of patients, in patterns suggesting a possible survivor effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472799     DOI: 10.1016/j.clinbiochem.2006.01.010

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  14 in total

1.  Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.

Authors:  Indranil Banerjee
Journal:  Eur J Epidemiol       Date:  2010-06-09       Impact factor: 8.082

2.  R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Authors:  Abdolkarim Mahrooz; Ghorban Gohari; Mohammad-Bagher Hashemi; Mehryar Zargari; Hadis Musavi; Mahmoud Abedini; Ahad Alizadeh
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

3.  Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Majken K Jensen; Eric B Rimm
Journal:  Circ J       Date:  2009-05-15       Impact factor: 2.993

4.  Serum Paraoxonase (PON1) Activity in North-West Indian Punjabi's with Acute Myocardial Infarction.

Authors:  V Nagarjuna Maturu; Nidhi Gupta; Gagandip Singh; Kirandip Gill; Yash Paul Sharma; Surjit Singh
Journal:  Indian J Clin Biochem       Date:  2012-10-11

5.  Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.

Authors:  Chiara Cristina Bortolasci; Heber Odebrecht Vargas; André Souza-Nogueira; Estefania Gastaldello Moreira; Sandra Odebrecht Vargas Nunes; Michael Berk; Seetal Dodd; Décio Sabbatini Barbosa; Michael Maes
Journal:  Redox Rep       Date:  2014-07-18       Impact factor: 4.412

6.  Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.

Authors:  Simon Cronin; Matthew J Greenway; Jochen H M Prehn; Orla Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

Review 7.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

Review 8.  Genetics of atherothrombotic and lacunar stroke.

Authors:  Stéphanie Debette; Sudha Seshadri
Journal:  Circ Cardiovasc Genet       Date:  2009-04

Review 9.  Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.

Authors:  Issa J Dahabreh; Georgios D Kitsios; David M Kent; Thomas A Trikalinos
Journal:  Genet Med       Date:  2010-10       Impact factor: 8.822

10.  Adaptations to climate in candidate genes for common metabolic disorders.

Authors:  Angela M Hancock; David B Witonsky; Adam S Gordon; Gidon Eshel; Jonathan K Pritchard; Graham Coop; Anna Di Rienzo
Journal:  PLoS Genet       Date:  2008-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.